Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Immunotherapy

DRUG CLASS:

Immunotherapy

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

PD-L1 expression	Triple Negative Breast Cancer	PD-L1 expression	Triple Negative Breast Cancer	Immunotherapy Sensitive: A2 - Guideline Immunotherapy Sensitive : A2	Immunotherapy Sensitive: A2 - Guideline Immunotherapy Sensitive : A2
No biomarker	Clear Cell Renal Cell Carcinoma	No biomarker	Clear Cell Renal Cell Carcinoma	Immunotherapy Sensitive: A2 - Guideline Immunotherapy Sensitive : A2	Immunotherapy Sensitive: A2 - Guideline Immunotherapy Sensitive : A2
No biomarker	Clear Cell Renal Cell Carcinoma	No biomarker	Clear Cell Renal Cell Carcinoma	Immunotherapy + VEGFR inhibitor Sensitive: A2 - Guideline Immunotherapy + VEGFR inhibitor Sensitive : A2	Immunotherapy + VEGFR inhibitor Sensitive: A2 - Guideline Immunotherapy + VEGFR inhibitor Sensitive : A2
No biomarker	Clear Cell Renal Cell Carcinoma	No biomarker	Clear Cell Renal Cell Carcinoma	Immunotherapy + Tyrosine kinase inhibitor Sensitive: A2 - Guideline Immunotherapy + Tyrosine kinase inhibitor Sensitive : A2	Immunotherapy + Tyrosine kinase inhibitor Sensitive: A2 - Guideline Immunotherapy + Tyrosine kinase inhibitor Sensitive : A2
KRAS G12C	Non Small Cell Lung Cancer	KRAS G12C	Non Small Cell Lung Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
TMB-H + PD-L1 overexpression	Non Small Cell Lung Cancer	TMB-H + PD-L1 overexpression	Non Small Cell Lung Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
KRAS G12C	Lung Non-Squamous Non-Small Cell Cancer	KRAS G12C	Lung Non-Squamous Non-Small Cell Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
PD-L1 expression	Gastric Cancer	PD-L1 expression	Gastric Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
PD-L1 expression	Gastroesophageal Junction Adenocarcinoma	PD-L1 expression	Gastroesophageal Junction Adenocarcinoma	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
TMB-H	Solid Tumor	TMB-H	Solid Tumor	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
MUC16 mutation	Non Small Cell Lung Cancer	MUC16 mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B
KRAS mutation	Non Small Cell Lung Cancer	KRAS mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B	Immunotherapy Sensitive: B - Late Trials Immunotherapy Sensitive : B